Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 3, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD-ILT, avian infectious laryngotracheitis,infectious bursal disease,Marek's disease vaccine (live recombinant),Newcastle disease virus vaccine (inactivated), Status: Opinion
Veterinary medicines European public assessment report (EPAR): Fluralaner Intervet, fluralaner, Status: Opinion
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 May 2025
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 15/05/2025 Positive
Summary of opinion: Stronghold Plus, 15/05/2025 Positive
Summary of opinion: NexGard Combo, 15/05/2025 Positive
Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised